相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。COVID-19 Serology at Population Scale: SARS-CoV-2-Specific Antibody Responses in Saliva
Pranay R. Randad et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2021)
IgA dominates the early neutralizing antibody response to SARS-CoV-2
Delphine Sterlin et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
Wilfredo F. Garcia-Beltran et al.
CELL (2021)
Immunopathological similarities between COVID-19 and influenza: Investigating the consequences of Co-infection
Hossein Khorramdelazad et al.
MICROBIAL PATHOGENESIS (2021)
Targets and strategies for vaccine development against SARS-CoV-2
Jonaid Ahmad Malik et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Saliva SARS-CoV-2 Antibody Prevalence in Children
Maya W. Keuning et al.
MICROBIOLOGY SPECTRUM (2021)
Aging and influenza vaccine-induced immunity
Haley L. Dugan et al.
CELLULAR IMMUNOLOGY (2020)
Measles, rubella, mumps and Toxoplasma gondii antibodies in saliva of vaccinated students of schools and universities in Sao Paulo City, Brazil
Barbara Carvalho Fialho Sampaio et al.
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES (2020)
Coronavirus infections and immune responses
Geng Li et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
Wanbo Tai et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)
Li Guo et al.
CLINICAL INFECTIOUS DISEASES (2020)
COVID-19 as an Acute Inflammatory Disease
Rose H. Manjili et al.
JOURNAL OF IMMUNOLOGY (2020)
Virology, Epidemiology, Pathogenesis, and Control of COVID-19
Yuefei Jin et al.
VIRUSES-BASEL (2020)
SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates
Gregory A. Poland et al.
LANCET (2020)
A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity
Angkana T. Huang et al.
NATURE COMMUNICATIONS (2020)
Natural versus Recombinant Viral Antigens in SARS-CoV-2 Serology: Challenges in Optimizing Laboratory Diagnosis of COVID-19
Luciana Regina Meireles et al.
CLINICS (2020)
SARS-CoV-2 identification and IgA antibodies in saliva: One sample two tests approach for diagnosis
Ada Aita et al.
CLINICA CHIMICA ACTA (2020)
Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients
Baweleta Isho et al.
SCIENCE IMMUNOLOGY (2020)
How to assess the effectiveness of nasal influenza vaccines? Role and measurement of sIgA in mucosal secretions
Elena Gianchecchi et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2019)
Development of Universal Influenza Vaccines Targeting Conserved Viral Proteins
Seyed Davoud Jazayeri et al.
VACCINES (2019)
Origin and evolution of pathogenic coronaviruses
Jie Cui et al.
NATURE REVIEWS MICROBIOLOGY (2019)
Immunogenicity of Influenza Vaccines: Evidence for Differential Effect of Secondary Vaccination on Humoral and Cellular Immunity
Sietske K. Rosendahl Huber et al.
FRONTIERS IN IMMUNOLOGY (2019)
IgA polymerization contributes to efficient virus neutralization on human upper respiratory mucosa after intranasal inactivated influenza vaccine administration
Yoshihiko Terauchi et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
Evaluating influenza vaccines: progress and perspectives
Elena Gianchecchi et al.
FUTURE VIROLOGY (2016)
Intranasal vaccination with a replication-deficient influenza virus induces heterosubtypic neutralising mucosal IgA antibodies in humans
A. Morokutti et al.
VACCINE (2014)
Refolding Techniques for Recovering Biologically Active Recombinant Proteins from Inclusion Bodies
Hiroshi Yamaguchi et al.
BIOMOLECULES (2014)
Role of T cell immunity in recovery from influenza virus infection
Jie Sun et al.
CURRENT OPINION IN VIROLOGY (2013)
Memory CD4+ T cells protect against influenza through multiple synergizing mechanisms
K. Kai McKinstry et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Sublingual immunization with recombinant adenovirus encoding SARS-CoV spike protein induces systemic and mucosal immunity without redirection of the virus to the brain
Byoung-Shik Shim et al.
VIROLOGY JOURNAL (2012)
Studies on the usefulness of intranasal inactivated influenza vaccines
Shin-ichi Tamura
VACCINE (2010)
Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infection
Lanying Du et al.
JOURNAL OF IMMUNOLOGY (2008)
Defective CD8 T cell memory following acute infection without CD4 T cell help
JC Sun et al.
SCIENCE (2003)
分享论文
